Langerhans cell histiocytosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 9: | Line 9: | ||
* Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term [[eosinophils|eosinophilic]] [[granuloma]] (Letterer–Siwe disease) to describe a similar clinical entity of the disease. | * Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term [[eosinophils|eosinophilic]] [[granuloma]] (Letterer–Siwe disease) to describe a similar clinical entity of the disease. | ||
* It was not until the year 1941 that Dr. Sidney Farber, a [[pathologist]] at [[Boston Children's Hospital]], unified the clinically similar conditions under the term histiocytosis X. | * It was not until the year 1941 that Dr. Sidney Farber, a [[pathologist]] at [[Boston Children's Hospital]], unified the clinically similar conditions under the term histiocytosis X. | ||
* Following the advances of [[electron microscopy]], the term [[Birbeck granules]] was first used to describe the particles found in Langerhan cells in 1961. | * Following the advances of [[electron microscopy]], the term [[Birbeck granules]] was first used to describe the particles found in Langerhan cells in 1961.<ref name="pmid11809842">{{cite journal |vauthors=Mc Dermott R, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M, Cazenave JP, Raposo G, Goud B, de la Salle H, Salamero J, Hanau D |title=Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates |journal=Mol. Biol. Cell |volume=13 |issue=1 |pages=317–35 |date=January 2002 |pmid=11809842 |pmc=65091 |doi=10.1091/mbc.01-06-0300 |url=}}</ref> | ||
* The [[phagocyte|phagocytic]] nature of Langerhan cells was first described in 1973 by Dr. Christian Nezelof.<ref name="pmid317149">{{cite journal| author=Nezelof C| title=Histiocytosis X: a histological and histogenetic study. | journal=Perspect Pediatr Pathol | year= 1979 | volume= 5 | issue= | pages= 153-78 | pmid=317149 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=317149 }} </ref> | * The [[phagocyte|phagocytic]] nature of Langerhan cells was first described in 1973 by Dr. Christian Nezelof.<ref name="pmid317149">{{cite journal| author=Nezelof C| title=Histiocytosis X: a histological and histogenetic study. | journal=Perspect Pediatr Pathol | year= 1979 | volume= 5 | issue= | pages= 153-78 | pmid=317149 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=317149 }} </ref> | ||
* The term Langerhans cell histiocytosis was finally agreed upon in 1987 by the the Writing Group of the Histiocyte Society. | * The term Langerhans cell histiocytosis was finally agreed upon in 1987 by the the Writing Group of the Histiocyte Society.<ref name="pmid30281871">{{cite journal |vauthors=Kobayashi M, Tojo A |title=Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment |journal=Cancer Sci. |volume=109 |issue=12 |pages=3707–3713 |date=December 2018 |pmid=30281871 |pmc=6272080 |doi=10.1111/cas.13817 |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 18:34, 23 March 2019
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis historical perspective |
|
Langerhans cell histiocytosis historical perspective in the news |
|
Blogs on Langerhans cell histiocytosis historical perspective |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The clinical presentation of Langerhans cell histiocytosis was first described by Dr. Alfred Hand Jr., an American pediatrician, in 1893.[1] The term histiocytosis X was first used to describe the disease by Dr. Sidney Farber, a pathologist at Boston Children's Hospital, in 1941. The term Langerhans cell histiocytosis was finally agreed upon in 1987 by the the Writing Group of the Histiocyte Society.[2][3]
Historical Perspective
- The clinical presentation of Langerhans cell histiocytosis was first described by Alfred Hand Jr., an American pediatrician, in 1893.[1]
- The term Hand-Schüller-Christian disease was first used to describe the clinical entity following the work of Dr. Artur Schüller and Dr. Henry Christian.[2]
- Between the years 1920 and 1940, Dr. Erich Letterer and Dr. Sture Siwe used the term eosinophilic granuloma (Letterer–Siwe disease) to describe a similar clinical entity of the disease.
- It was not until the year 1941 that Dr. Sidney Farber, a pathologist at Boston Children's Hospital, unified the clinically similar conditions under the term histiocytosis X.
- Following the advances of electron microscopy, the term Birbeck granules was first used to describe the particles found in Langerhan cells in 1961.[4]
- The phagocytic nature of Langerhan cells was first described in 1973 by Dr. Christian Nezelof.[3]
- The term Langerhans cell histiocytosis was finally agreed upon in 1987 by the the Writing Group of the Histiocyte Society.[5]
References
- ↑ 1.0 1.1 DiCaprio MR, Roberts TT (2014). "Diagnosis and Management of Langerhans Cell Histiocytosis". J Am Acad Orthop Surg. 22 (10): 643–652. doi:10.5435/JAAOS-22-10-643. PMID 25281259.
- ↑ 2.0 2.1 Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ (2013). "Pathogenesis of Langerhans cell histiocytosis". Annu Rev Pathol. 8: 1–20. doi:10.1146/annurev-pathol-020712-163959. PMID 22906202.
- ↑ 3.0 3.1 Nezelof C (1979). "Histiocytosis X: a histological and histogenetic study". Perspect Pediatr Pathol. 5: 153–78. PMID 317149.
- ↑ Mc Dermott R, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M, Cazenave JP, Raposo G, Goud B, de la Salle H, Salamero J, Hanau D (January 2002). "Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates". Mol. Biol. Cell. 13 (1): 317–35. doi:10.1091/mbc.01-06-0300. PMC 65091. PMID 11809842.
- ↑ Kobayashi M, Tojo A (December 2018). "Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment". Cancer Sci. 109 (12): 3707–3713. doi:10.1111/cas.13817. PMC 6272080. PMID 30281871.